English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51902398    線上人數 :  990
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"liu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 701-710 / 1570 (共157頁)
<< < 66 67 68 69 70 71 72 73 74 75 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-15T07:59:52Z Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan Wang C.-H.;Chen C.-J.;Chung-Yi Hu;You S.-L.;Chu C.-T.;Chou M.-J.;Essex M.;Blattner W.A.;Liu C.-H.;Yang C.-S.; Wang C.-H.; Chen C.-J.; CHUNG-YI HU; You S.-L.; Chu C.-T.; Chou M.-J.; Essex M.; Blattner W.A.; Liu C.-H.; Yang C.-S.
臺大學術典藏 2021-03-15T07:59:52Z Infection of human T-cell leukemia virus type I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasms: A possible linkage to blood transfusion Chen Y.-C.;Wang C.-H.;Su I.-J.;Chung-Yi Hu;Chou M.-J.;Lee T.-H.;Lin D.-T.;Chung T.-Y.;Liu C.-H.;Yang C.-S.; Chen Y.-C.; Wang C.-H.; Su I.-J.; CHUNG-YI HU; Chou M.-J.; Lee T.-H.; Lin D.-T.; Chung T.-Y.; Liu C.-H.; Yang C.-S.
臺大學術典藏 2021-03-12T02:28:42Z Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load Wang J.-Y.;Liu C.-H.;Hu F.-C.;Chang H.-C.;Liu J.-L.;Chen J.-M.;Yu C.-J.;Li-Na Lee;Kao J.-H.;Yang P.-C.; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; LI-NA LEE; Kao J.-H.; Yang P.-C.
臺大學術典藏 2021-03-09T06:46:21Z Hodgkin's disease and non?hodgkin's lymphoma containing reed?sternberg?like giant cells in Taiwan: A clinicopathologic analysis of 50 cases RUEY-LONG HONG; Su I.?J.; Chen Y.?C.; Hsieh H.?C.; Wang C.?H.; Liu C.?H.; Shen M.?C.
臺大學術典藏 2021-03-09T01:47:47Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B TUNG-HUNG SU; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; TUNG-HUNG SU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.

顯示項目 701-710 / 1570 (共157頁)
<< < 66 67 68 69 70 71 72 73 74 75 > >>
每頁顯示[10|25|50]項目